Advertisement
IDEAYA Biosciences Q4 Results Misses Estimates
(RTTNews) - IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced net loss of $32.64 million or $0.52 per share, wider than $23.07 million or $0.50 per share in the prior-year quarter.
Collaboration revenues for the quarter declined to $3.92 million from $4.02 million in the same quarter last year.
On average, ten analysts polled by Thomson Reuters expected the company to report a loss of $0.47 per share on revenues of $8.84 million for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).
RTTNews
|
vor 814 Tagen
IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced that Darrin Beaupre has joined the company as its Chief Medical Officer, effective November 21, 2022.
RTTNews
|
vor 1080 Tagen
TSX Scales New Record High; Materials, Financials Stocks Among Top Gainers
Canada's S&P/TSX Composite Index surged to a new record high on Wednesday with stocks from materials, financials, consumer staples and industrials sectors turning in a strong performance.
The mood in the market is quite bullish amid hopes the government shutdown in the U.S. will come to end soon.
RTTNews
|
vor 3Std 20 Minuten
Swiss Market Settles On Firm Note
The Switzerland market closed on a firm note on Wednesday, tracking positive cues from other markets in Europe, amid rising prospects of an end to the U.S. government shutdown this week, and hopes about an interest rate cut by the Federal Reserve next month.
RTTNews
|
vor 3Std 43 Minuten
European Stocks Close On Firm Note
European stocks closed higher on Wednesday, extending recent gains, amid hopes the U.S. government shutdown will end soon, possibly even by this Friday.
Expectations of a rate cut by the Federal Reserve next month, and data showing a smaller than expected increase in Germany's consumer price inflation also contributed to markets' positive close.
RTTNews
|
vor 3Std 56 Minuten
Bay Street May Open On Positive Note Again
Canadian stocks may open higher on Wednesday amid optimism about an end to the U.S. government shutdown. Firm European stocks and expectations of an interest rate cut by the Federal Reserve next month may also help underpin sentiment.
RTTNews
|
vor 8Std 19 Minuten
FTSE 100 Pares Early Gains; SSE Soars 12%
After opening marginally higher and moving up a bit subsequently, the U.K. market's FTSE 100 slipped into negative territory on Wednesday, with investors looking for direction and largely refraining from making significant moves.
RTTNews
|
vor 9Std 37 Minuten
CAC 40 Extends Gains To 3rd Straight Day, Rises Over 1%
French stocks are up in positive territory on Wednesday, extending gains to a third straight session, led by gains in financial and luxury sectors.
Expectations of an interest rate cut by the Federal Reserve next month, and hopes that the government shutdown in the U.S. will likely end this week help underpin sentiment.
RTTNews
|
vor 10Std 34 Minuten
